ロード中...
LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone
Despite recent advances, the myeloproliferative neoplasms (MPNs) are attended by considerable morbidity and mortality. Janus kinase (Jak) inhibitors such as ruxolitinib manage symptoms but do not substantially change the natural history of the disease. In this report, we show the effects of IMG-7289...
保存先:
| 出版年: | Hemasphere |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Health
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6745991/ https://ncbi.nlm.nih.gov/pubmed/31723778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000054 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|